Delivery Order SPE2DB20D2014-SPE2DB24FC50G

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,408.14, is a Delivery Order for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024, and is a Firm Fixed Price contract. This award is not associated with a set-aside program. In addition to this...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,170.49, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,440.96, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract has a firm fixed price and an ultimate completion date of July 11, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,920.03 firm fixed-price contract is to provide 4563829960 - VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular health medication. The contract has an ultimate completion date of March 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,830.00, is for the delivery of the pharmaceutical product VALSARTAN-HCTZ 160-25 MG TAB 90S. The contract is a firm fixed-price delivery order and does not have a set-aside designation. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,133.66 firm fixed-price contract is for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of June 4, 2024 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,531.89 firm-fixed-price contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets, with a performance period through January 2, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,546.25 firm-fixed-price delivery order is for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of February 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,880.39 firm fixed-price contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of July 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,254.40 for the provision of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of November 16, 2023 and is a Firm Fixed Price arrangement. This award is a part of AmerisourceBergen's broader Indefinite Delivery Contract...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC50G
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,078.45, is for the provision of 4565177833 ! VALSARTAN-HCTZ 160-25 MG TAB 90S and has an ultimate completion date of July 18, 2024.

The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the pharmaceutical product to fulfill the government's requirements. The DLA, a defense agency, is the funding agency for this contract, which aligns with its mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other federal agencies.

Generated 5/17/25, 9:42 AM